Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Disease Extent in Stage IV Lobular Carcinoma: the Aid of Imaging and Liquid Biopsy Analyses

NCT07635654 is registered in ClinicalTrials.gov with KU Leuven as lead sponsor.

NCT NCT07635654
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07635654 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Disease Extent in Stage IV Lobular Carcinoma: the Aid of Imaging and Liquid Biopsy Analyses
Lead sponsor
KU Leuven
Phase
Not applicable
Overall status
Not yet recruiting
Start date
July 1, 2026
Completion date
June 30, 2030
Enrollment
43 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

invasive lobular breast carcinoma